Thus, despite several limitations the conclusions of this study have a potential impact on the development of novel treatment strategies for advanced PCa, proposing a new concept of OPRK1 inhibition to block the adaptation pathway for PCa toward CRPC progression. Here, OPRK1 is linked to posterior cortical atrophy.